Global Nucleic Acid Isolation And Purification Market To Reach $5,010.3 Million By 2031

By Author: bis
Total Articles: 68
Comment this article

The premium market intelligence report published by BIS Research, Global Nucleic Acid Isolation and Purification Market, highlights that the market is projected to reach $5.0 billion by 2031. The study also highlights that the market is set to witness a CAGR of 7.20% during the period 2021-2031. The growth of the market is attributed to factors driving it, including increasing adoption of genetic testing, decreasing cost of sequencing, and growing prevalence of infectious diseases, among others.

Nucleic acid testing is a molecular-based technique that allows the quantification and analysis of DNA/RNA, microbiome, and other biomolecules from various samples, including saliva, blood, serum, plasma, microbes, plants, and tissue, among others. Nucleic acid testing performed through polymerase chain reaction, next-generation sequencing, and microarray enables high-quality yield results due to higher sensitivity leading to better analysis than the serological-based methods.

Browse 47 Market Data Tables and 288 Figures spread through 395 Pages and in-depth TOC on Global Nucleic Acid Isolation and Purification Market

The ...
... comprehensive study of the global nucleic acid isolation and purification market by BIS Research covers the following:

Market numbers on micro-segments that are influencing the market 
More than 2000 products present in the market.
Market share analysis for more than 30 companies
End-user preference data for over 20 end users
Detailed global and regional market share analysis, including the scrutiny of more than 15 countries.  
Study of data of more than 30 companies
Who Should Buy this Report?

Manufacturers of sequencing instruments, kits, assays, and consumables
Companies involved in drug manufacturing and diagnostics development
Companies in the services market such as contract research organization
Companies involved in the development of bioinformatics tools for data analysis
Companies offering large scale testing services and custom assay development

View the Report from BIS Research: Global Nucleic Acid Isolation and Purification Market

To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include end user and market share analysis, growth share analysis, workflow, nucleic acid type, sample type, source type, technology, application, end user, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.

The market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, including the higher adoption of genetic tests for early diagnosis for various chronic conditions such as cancer, prenatal screening, and infectious diseases, increasing the need for sophisticated solutions for rapid and cost-effective analysis of DNA/RNA from various samples such as virus, FFPE-tissue, and blood.

The sample and source type of global market include data analysis on preferred kit type for nucleic acid isolation and purification analysis, current unmet need for the analysis of a specific sample, opportunities existing in the development of kits and automated instruments for DNA/RNA extraction and isolation.

The end user and product analysis of the global market includes data analysis on the satisfaction level of different kits and assays and services offered by the leading and emerging companies. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and services. The consumables are further categorized into kits and reagents.

Emphasizing on the dominance of the research and academic organizations over the applied testing segment under the end user category of the nucleic acid testing market in 2020 and 2031, Nitish Singh, Principal Analyst, BIS Research, states, "The reason for market growth can be attributed to the large-scale research and development along with several sequencing initiatives taken globally. The increasing disease burden, including the current COVID-19 pandemic, has led to large capital investments by key players in research and development for the development of highly sensitive and specific solutions to reduce the sample preparation and yield better quality nucleic acids for further downstream applications.

Request for a Sample:

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), New England Biolabs, Inc., Promega Corporation, Merck KGaA, Takara Bio Inc., QIAGEN N.N., Thermo Fisher Scientific Inc., and Promega Corporation.

The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.